JPS59108760A - Preparation of cystamine sulfate - Google Patents

Preparation of cystamine sulfate

Info

Publication number
JPS59108760A
JPS59108760A JP21706582A JP21706582A JPS59108760A JP S59108760 A JPS59108760 A JP S59108760A JP 21706582 A JP21706582 A JP 21706582A JP 21706582 A JP21706582 A JP 21706582A JP S59108760 A JPS59108760 A JP S59108760A
Authority
JP
Japan
Prior art keywords
sulfate
cystamine
aqueous solution
alcohol
dialkylthiazolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP21706582A
Other languages
Japanese (ja)
Inventor
Michio Tsuchiya
土屋 美智雄
Yutaka Morimoto
豊 森本
Akihiro Sawamura
澤村 明広
Futoshi Kitagawa
北川 太
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shokubai Co Ltd
Original Assignee
Nippon Shokubai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shokubai Co Ltd filed Critical Nippon Shokubai Co Ltd
Priority to JP21706582A priority Critical patent/JPS59108760A/en
Publication of JPS59108760A publication Critical patent/JPS59108760A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:To prepare the titled compound in high yield and purity, easily, without producing by-products, by oxidizing a reaction liquid containing cysteamine sulfate and derived from an aqueous solution of 2,2-dialkylthiazolidine, and crystallizing and separating the objective compound using a specific alcohol. CONSTITUTION:An aqueous solution of 2,2-dialkylthiazolidine of formula (R1 and R2 are 1-3C lower alkyl) (e.g. 2,2-dimethylthiazolidine) is hydrolyzed with sulfuric acid to obtain an aqueous solution of the reaction products containing cysteamine sulfate. The aqueous solution is oxidized with hydrogen peroxide to obtain cystamine sulfate solution, and the cystamine sulfate is crystallized and separated therefrom by the addition of a 1-4C lower aliphatic alcohol (e.g. methyl or ethyl alcohol, etc.). The amount of sulfuric acid is preferably 0.8- 1.1mol per 1mol of the compound of formula. The process is economically advantageous since it requires only a moderate amount of alcohol.

Description

【発明の詳細な説明】 本発明は高純度シスタミン硫酸塩を効率良く製造する方
法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for efficiently producing high purity cystamine sulfate.

シスタミン硫酸塩の製造方法として、例えば特開昭55
−127360号明細書記載の方法がある。この従来公
知の方法は、システアミン塩酸塩水溶液をアルカリ(例
えば水酸化ナトリウム)で中和し、過酸化水素を加えて
酸化しシスタミン水溶液とし、濃縮しだ後低級脂肪族ア
ルコールに溶解させ、その際晶出する副生塩(例えば塩
化す) IJウム)を戸別除去し、次いでシスタミンの
アルコール性液に桃酸を滴下し目的とするシスタミン硫
酸塩を晶出分離するものである。しかし、シスタミンの
アルコール性液に硫酸を加えたのでは副生物が生成し、
シスタミン硫酸塩晶出時に当該副生物を含むこととなり
、着色し純度の低いものになってし捷う欠点を持ってい
る。又、システアミン塩酸塩の脱塩酸工程、ソステアミ
ン水溶液の濃縮工程、副生塩(例えば塩化す) IJウ
ム)の除去工程などの多くの工程を必要としている。更
に、脱塩酸により生成する副生塩(例えば塩化ナトリウ
ム)の除去を完全に行なうことが困難であることから、
製品への混入は避けられず、この点からも純度低下の原
因を持っている。
As a method for producing cystamine sulfate, for example, JP-A-55
There is a method described in the specification of No.-127360. This conventionally known method involves neutralizing an aqueous solution of cysteamine hydrochloride with an alkali (e.g., sodium hydroxide), adding hydrogen peroxide to oxidize it to obtain an aqueous cystamine solution, concentrating it, and then dissolving it in a lower aliphatic alcohol. Crystallized by-product salts (for example, chloride) are removed one by one, and peach acid is then added dropwise to the alcoholic cystamine solution to crystallize and separate the desired cystamine sulfate. However, when sulfuric acid is added to the alcoholic solution of cystamine, by-products are generated.
When cystamine sulfate is crystallized, it contains the by-product, which has the drawback of being colored and having a low purity. In addition, many steps are required, such as a dehydrochlorination step for cysteamine hydrochloride, a step for concentrating an aqueous sosteamine solution, and a step for removing by-product salts (for example, IJ chloride). Furthermore, since it is difficult to completely remove by-product salts (e.g., sodium chloride) generated by dehydrochlorination,
Contamination with products is unavoidable, and this also causes a decrease in purity.

本発明者らは、従来方法の欠点を見服し、高純度シスタ
ミン硝酸塩を製造する方法について鋭意研究した結果、
2,2−ジアルキルチアゾリジンの水溶液を宿r酸で加
水分解しシステアミン硫酸塩水溶液とし、それに過酸化
水素を加えてシスタミン硫酸塩水溶液とした後、炭素数
1乃至4の低級脂肪$ フルコールを加えてシスタミン
硫酸塩を晶出させ分離することにより高純度シスタミン
硫酸塩を収率良く簡単な工程で製造できることを見出し
て本発明を完成させたものである。
The present inventors have overlooked the shortcomings of conventional methods, and as a result of intensive research into a method for producing high-purity cystamine nitrate,
An aqueous solution of 2,2-dialkylthiazolidine was hydrolyzed with a teracid acid to obtain an aqueous cysteamine sulfate solution, hydrogen peroxide was added thereto to obtain an aqueous cystamine sulfate solution, and then a lower fat having 1 to 4 carbon atoms was added. The present invention was completed by discovering that high-purity cystamine sulfate can be produced with high yield and in a simple process by crystallizing and separating cystamine sulfate.

本発明の製造法は、一般式 (式中、R1及びR2は各々独立して炭素数1乃13の
低級アルキル基を示す。) で表わされる2、2−ジアルキルチアゾリジンの水溶液
に硫酸を加え加水分解せしめて得られるシステアミン硫
酸塩を含む反応生成水溶液に過酸化水素を加え酸化反応
せしめシスタミンVte塩水溶液とした後、炭素数1乃
至4の低級脂肪族アルコールを加えてシスタミン硫酸塩
を晶出させ分離することを特徴とするものである。
The production method of the present invention involves adding sulfuric acid to an aqueous solution of 2,2-dialkylthiazolidine represented by the general formula (wherein R1 and R2 each independently represent a lower alkyl group having 1 to 13 carbon atoms) and adding hydration. Hydrogen peroxide is added to the reaction product aqueous solution containing cysteamine sulfate obtained by decomposition to cause an oxidation reaction to obtain a cystamine Vte salt aqueous solution, and then a lower aliphatic alcohol having 1 to 4 carbon atoms is added to crystallize cystamine sulfate. It is characterized by separation.

2.2−ジアルキルチアゾリジン水溶液i2.2−ジア
ルキルチアゾリジンと水から成るもので、例えば2,2
−ジアルキルチアゾリジンを水に溶解することにより容
易に調製することができる。この際、2,2−ジアルキ
ルチアゾリジン濃度に関しては特にft1lJ限(徒な
いが、シスタミン硫酸塩水溶液調製段階で該塩濃度が3
5重量係以上を与える比較的高湿度とするのが好ましい
。このような法度とすることにより、シスタミン硫酸塩
晶出段階での収率を旨めることができる。
2.2-Dialkylthiazolidine aqueous solution i2.It consists of 2-dialkylthiazolidine and water, for example 2,2
- Can be easily prepared by dissolving dialkylthiazolidine in water. At this time, the 2,2-dialkylthiazolidine concentration is particularly limited to the ft1lJ limit (although it is inevitable that the salt concentration was
Preferably, the humidity is relatively high, giving a weight factor of 5 or more. By using such a moderate amount, the yield at the cystamine sulfate crystallization step can be improved.

2.2−ジアルキルチアゾリジンは前記一般式で表わさ
れる化合物であり、例えば2,2−ジメチルチアゾリジ
ン;2−メチル、2−エチルチアゾリジン;2−メチル
、2−プロピルチアゾリジンなどを挙げることができる
。2,2−ジアルキルチアゾリジンは、エチレンイミン
より容易に高収率で得られるので、本発明に於る原料入
手は容易である(Ann、 Chem、 566、21
0. (1950) )。
2.2-Dialkylthiazolidine is a compound represented by the above general formula, and includes, for example, 2,2-dimethylthiazolidine; 2-methyl, 2-ethylthiazolidine; and 2-methyl, 2-propylthiazolidine. Since 2,2-dialkylthiazolidine can be obtained more easily and in higher yields than ethyleneimine, raw materials for the present invention are easily available (Ann, Chem, 566, 21
0. (1950)).

本発明に於るシステアミン硫酸塩を含む反応生成水溶液
は、上記の如き比較的高濃度の2,2−ジアルキルチア
ゾリジン水溶液に硫酸を加え、100〜150℃の範囲
の温度、3〜10時間、発生するケトンを系外へ留去さ
せつつ加水分解させることにより調製されたものである
。硫酸の使用量は、2.2−ジアルキルチアシリシアー
1モルに対して硫酸O,S〜1.1モルの範囲の割合の
量とするのが好ましい。0.8モル未満の割合の量とし
たのでは加水分解が不充分となシ製品の収率低下や純度
低下をきだし、逆に1.1モルを越える割合の量とした
のでは製品中に硫酸が残り、後で精製工程が必要となっ
てくるので経済的ではない。又、該反応生成水溶液には
システアミン硫酸塩の他に副生ずるシスタミン硫酸塩を
含むが、本発明に於ては何ら問題とならない。
The reaction product aqueous solution containing cysteamine sulfate in the present invention is produced by adding sulfuric acid to the above-mentioned relatively high concentration 2,2-dialkylthiazolidine aqueous solution and generating it at a temperature in the range of 100 to 150°C for 3 to 10 hours. It was prepared by hydrolyzing the ketone while distilling it out of the system. The amount of sulfuric acid used is preferably in the range of 1.1 moles of sulfuric acid O,S per 1 mole of 2,2-dialkylthiasilicia. If the amount is less than 0.8 mol, the hydrolysis will be insufficient, resulting in a decrease in the yield and purity of the product, while if the amount is more than 1.1 mol, the product will be degraded. It is not economical because sulfuric acid remains in the solution and a purification step is required later. In addition, the reaction product aqueous solution contains cystamine sulfate as a by-product in addition to cysteamine sulfate, but this does not pose any problem in the present invention.

シスタミン硫酸塩水溶液は上記の如き反応生成水溶液に
過酸化水素を加え0〜60℃の範囲の温度で酸化反応せ
しめることにより調製されたものである。この際、未反
応システアミン硫酸塩濃度が1重量幅以下になるまで酸
化反応を行なうことが好ましい。過酸化水素としては、
市販のもの、例えば35係濃度の過酸化水素水溶液を用
いるのが便利である。該反応生成水溶液中のシスタミン
硫酸塩濃度に関しては、35〜50重量係の範囲の比較
的高濃度とするのが好ましい。例えばブステアミン硫酸
塩50重量係濃度の反応生成水溶液に35重量係濃度の
過酸化水素水溶液を加えて酸化反応せしめることにより
、約40重量濃度度のシスタミン値e塩水溶液を調製し
、当該濃度のシスタミン硫酸塩水溶液を用いると以後の
工程に於る操作を容易にしかつ高収率で高純度のシスタ
ミン硫酸塩を晶出させることができるので好適である。
The cystamine sulfate aqueous solution was prepared by adding hydrogen peroxide to the reaction product aqueous solution as described above and causing an oxidation reaction at a temperature in the range of 0 to 60°C. At this time, it is preferable to carry out the oxidation reaction until the concentration of unreacted cysteamine sulfate becomes 1 weight range or less. As hydrogen peroxide,
It is convenient to use a commercially available solution, for example, an aqueous hydrogen peroxide solution with a concentration of 35%. The cystamine sulfate concentration in the reaction product aqueous solution is preferably relatively high in the range of 35 to 50% by weight. For example, by adding an aqueous hydrogen peroxide solution having a concentration by weight of 35 to a reaction product aqueous solution of busteamine sulfate having a concentration by weight of 50 to cause an oxidation reaction, a cystamine value e salt aqueous solution having a concentration by weight of about 40 is prepared. It is preferable to use an aqueous sulfate solution because it facilitates operations in subsequent steps and allows crystallization of cystamine sulfate with high yield and purity.

シスタミン硫酸塩の晶出は、上記の如き比較的高濃度の
シスタミン硫酸塩水溶液に例えば35重it 幅以上の
濃度のシスタミン硫酸塩水溶液に炭素数1乃至4の低級
脂肪族アルコールを加えることにより行なうものである
。この際、系の温度は、0〜60℃の範囲とするのが好
ましい。該アルコールの使用量は、該アルコール添加後
のシスタミン硫酸塩濃度が20〜30重量係の範囲にな
るような量にするのが好ましい。20重量係未満になる
ような多量の該アルコールを用いたのでは、シスタミン
硫酸塩の炉液中に移行する分が多くなるので好ましくな
い。又、系の容積の割に生産量が少なくなるので好まし
くない。逆に300重量を越えるような少量の該アルコ
ールを用いたのでは、晶出したシスタミン硫酸塩がペー
スト状になり易く、ペースト状になってし甘うと炉別操
作が困難になるので好ましくない。該アルコールさして
は、例えばメチルアルコール、エチルアルコール、n−
プロピルアルコール、イソプロピルアルコール、ブチル
アルコールなどを挙げることができる。
Crystallization of cystamine sulfate is carried out by adding a lower aliphatic alcohol having 1 to 4 carbon atoms to a cystamine sulfate aqueous solution having a relatively high concentration as described above, for example, at a concentration of 35% or more. It is something. At this time, the temperature of the system is preferably in the range of 0 to 60°C. The amount of alcohol used is preferably such that the concentration of cystamine sulfate after addition of the alcohol is in the range of 20 to 30% by weight. If a large amount of the alcohol is used, such as less than 20% by weight, a large amount of cystamine sulfate will migrate into the furnace solution, which is not preferable. Furthermore, the production volume is undesirably small compared to the volume of the system. On the other hand, if a small amount of the alcohol exceeding 300% by weight is used, the crystallized cystamine sulfate tends to become paste-like, and if it becomes pasty, it becomes difficult to separate the mixture in a furnace, which is not preferable. Examples of the alcohol include methyl alcohol, ethyl alcohol, n-
Examples include propyl alcohol, isopropyl alcohol, and butyl alcohol.

シスタミン硫酸塩の晶出は、比較的高濃度のシスタミン
代醋塩水溶液を用い、副生物や余分な硫酸のない条件下
で行われるので、高純度シスタミンWc (39塩を効
率良く得ることができる。又、アルコール使用量も適量
で済むことから、経済的である。
The crystallization of cystamine sulfate is carried out using a relatively highly concentrated aqueous solution of cystamine salt in the absence of by-products and excess sulfuric acid, making it possible to efficiently obtain highly purified cystamine Wc (39 salt). Moreover, it is economical because only a moderate amount of alcohol is used.

晶出したシスタミン硫酸塩は、戸別することにより、系
よジ容易に分離することができる。P液は、次の晶出操
作に於るアルコールとして有効に再利用できるものであ
る。分離後減圧下で約70℃の温度で乾燥すると、白色
でサラサラし7た結晶のシスタミン硫酸塩が得られる。
The crystallized cystamine sulfate can be easily separated from the system by separating it from house to house. The P solution can be effectively reused as alcohol in the next crystallization operation. After separation, it is dried under reduced pressure at a temperature of about 70°C to obtain white, smooth, crystalline cystamine sulfate.

このものは、減圧下での乾燥波間:が6〜7重量幅の範
囲にあることから、恐らくシスタミン硫酸1水塩になっ
ているものと考えられる。しかし、このような結晶形だ
けで本発明が制限されるものではない。
Since this product has a dry wave length in the range of 6 to 7 weight range under reduced pressure, it is considered that it is probably cystamine sulfate monohydrate. However, the present invention is not limited only to such crystal forms.

以下、実施例により本発明を更に詳しく説明する。Hereinafter, the present invention will be explained in more detail with reference to Examples.

実施例 1 50重量係濃度の2,2−ジメチルチアゾリジン水溶液
400りに、30℃以下の温度に保ちながら、礎硫酸(
98重量係)852を加え中和した。
Example 1 Basic sulfuric acid (
98 weight ratio) was added to neutralize.

中和した水溶液を蒸留して発生するアセトンを留去せし
めつつ加水分解を行ない、更に加水分解を完全にするた
め濃縮してシステアミン硫酸塩濃度70重量係の反応生
成水溶液を得た。次いで、水を加えて濃度を50重量係
に調整した。この水溶液に35重量係濃度の過酸化水素
水溶液を加え、約40℃に保ちながら酸化反応せしめた
。酸化反応は、ヨウ素滴定法により一8H基量を測定し
、未反応システアミン硫酸塩濃度が0.1重景係以下と
なるまで進めた。反応生成水溶液4852が得られた。
The neutralized aqueous solution was distilled to perform hydrolysis while distilling off the generated acetone, and further concentrated to complete the hydrolysis to obtain a reaction product aqueous solution having a cysteamine sulfate concentration of 70% by weight. Water was then added to adjust the concentration to 50% by weight. An aqueous hydrogen peroxide solution having a concentration of 35% by weight was added to this aqueous solution, and an oxidation reaction was carried out while maintaining the temperature at about 40°C. The oxidation reaction was carried out until the concentration of unreacted cysteamine sulfate was 0.1 or less by measuring the amount of -8H groups by iodometric titration. A reaction product aqueous solution 4852 was obtained.

臭素酸カリ法により−SS−基を分析しシスタミン硫酸
塩濃度を測定したところ43.8重i%であり、2,2
−ジメチルチアゾリジンに対する収率が99,3重量幅
であった。
When the -SS- group was analyzed by the potassium bromate method and the cystamine sulfate concentration was measured, it was 43.8 weight i%, 2,2
-The yield based on dimethylthiazolidine was 99.3% by weight.

このようにして得られたシスタミン硫酸塩水溶液にメチ
ルアルコールを該塩濃度が25重量係になるまで加え、
20℃の温度に保ちながらシスタミン硫酸塩を晶出させ
た。次いで戸別し乾燥し、白色のシスタミン硫酸塩結晶
を得だ。収率は、95幅であった。この結晶の純度は、
99.3 %であった。
Add methyl alcohol to the cystamine sulfate aqueous solution obtained in this way until the salt concentration becomes 25% by weight,
Cystamine sulfate was crystallized while maintaining the temperature at 20°C. The mixture was then dried separately to obtain white cystamine sulfate crystals. The yield was 95%. The purity of this crystal is
It was 99.3%.

実施例 2 実施例1に於て2,2−ジメチルチアゾリジンの代すに
2−メチル、2−エチルチアゾリジンを用いる他は同様
の手順に従ってシスタミン硫酸塩水溶液を調製した。収
率は、98.5 %であった。
Example 2 A cystamine sulfate aqueous solution was prepared in the same manner as in Example 1 except that 2-methyl, 2-ethylthiazolidine was used instead of 2,2-dimethylthiazolidine. The yield was 98.5%.

次いで、メチルアルコールの代りにイソプロピルアルコ
ールを用いる他は同様の手順に従ってシスタミン硫酸塩
結晶を得た。収率は、97係であった。結晶の純度は、
99.1係であった。
Cystamine sulfate crystals were then obtained by following the same procedure except that isopropyl alcohol was used instead of methyl alcohol. The yield was 97%. The purity of the crystal is
I was in charge of 99.1.

Claims (1)

【特許請求の範囲】 1、一般式 (式中、R1及びR2は各々独立して炭素数1乃至3の
低級アルキル基を示す。) で表わされる2、2−ジアルキルチアゾリジンの水溶液
に硫酸を加え加水分解せしめて得られるシステアミン硫
酸塩を含む反応生成水溶液に過酸化水素を加え酸化反応
せしめシスタミン硫酸塩水溶液とした後、炭素数1乃至
4の低級脂肪族アルコールを加えてシスタミン硫酸塩を
晶出させ分離するととを特徴とするシスタミン硫酸塩の
製造法。 2、硫酸の使用量は2,2−ジアルキルチアゾリジン1
モルに対して音酸0,8〜1,1モルの範囲の割合の量
である特許請求の範囲第1項記載の製造法。
[Claims] 1. Adding sulfuric acid to an aqueous solution of 2,2-dialkylthiazolidine represented by the general formula (wherein R1 and R2 each independently represent a lower alkyl group having 1 to 3 carbon atoms) Hydrogen peroxide is added to the reaction product aqueous solution containing cysteamine sulfate obtained by hydrolysis to cause an oxidation reaction to form a cystamine sulfate aqueous solution, and then a lower aliphatic alcohol having 1 to 4 carbon atoms is added to crystallize cystamine sulfate. A method for producing cystamine sulfate, the method comprising: separating the cystamine sulfate; 2. The amount of sulfuric acid used is 2,2-dialkylthiazolidine 1
2. The method according to claim 1, wherein the amount is in the range of 0.8 to 1.1 moles of sonic acid per mole.
JP21706582A 1982-12-13 1982-12-13 Preparation of cystamine sulfate Pending JPS59108760A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21706582A JPS59108760A (en) 1982-12-13 1982-12-13 Preparation of cystamine sulfate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21706582A JPS59108760A (en) 1982-12-13 1982-12-13 Preparation of cystamine sulfate

Publications (1)

Publication Number Publication Date
JPS59108760A true JPS59108760A (en) 1984-06-23

Family

ID=16698278

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21706582A Pending JPS59108760A (en) 1982-12-13 1982-12-13 Preparation of cystamine sulfate

Country Status (1)

Country Link
JP (1) JPS59108760A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55127360A (en) * 1979-03-26 1980-10-02 Seitetsu Kagaku Co Ltd Preparation of cystamine sulfate
JPS568358A (en) * 1979-07-04 1981-01-28 Sogo Yatsukou Kk Production of cysteamine mineral acid salt

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55127360A (en) * 1979-03-26 1980-10-02 Seitetsu Kagaku Co Ltd Preparation of cystamine sulfate
JPS568358A (en) * 1979-07-04 1981-01-28 Sogo Yatsukou Kk Production of cysteamine mineral acid salt

Similar Documents

Publication Publication Date Title
US2527366A (en) Production of amino acids
EP0213785B1 (en) Method for optical resolution of dl-cysteine and (r,s)-1-(1-naphthyl)ethylamine
JPS61293949A (en) Optical resolution of alpha-isopropyl-p-chlorophenylacetic acid
US4294766A (en) Preparation of pure potassium ribonate and ribonolactone
JPS59108760A (en) Preparation of cystamine sulfate
NO150515B (en) PROCEDURE FOR PREPARING 5`-DEOXY-5`-METHYLTHIOADENOSINE
US11046705B1 (en) Method for preparing etodolac methyl ester
JP3003287B2 (en) Method for producing sodium N-alkylaminoethanesulfonate
RU2001909C1 (en) Method of captopril synthesis
US3153077A (en) Process for preparing organic bis-thiosulfates
US3912778A (en) Process for the preparation of 3-keto-glutaric acid by carboxylation of acetone in glime
JP3011493B2 (en) Method for producing 4-alkyl-3-thiosemicarbazide
JP2001187778A (en) METHOD FOR PRODUCING beta-MERCAPTOPROPIONIC ACID
US4288610A (en) Purification of pyrethroid intermediate compounds by selective partial saponification
Streitwieser Jr et al. Stereochemistry of the Primary Carbon. XI. Ethanolysis of Optically Active Benzyl-α-d p-Toluenesulfonate1
JPS59108761A (en) Preparation of cystamine sulfate
JP3003288B2 (en) Method for producing sodium N-alkylaminoethanesulfonate
JPS59110667A (en) Production of cystamine sulfate
KR860001900B1 (en) A process for preparing-chloroalanine
JPH01193245A (en) Production of s-carboxymethyl-l-cysteine
JP2995576B2 (en) Purification method of 4,6-dimethoxy-2-methanesulfonylpyrimidine
US4263454A (en) Lithium ribonate, lithium arabonate and the preparation and purification of these salts
JPS62288102A (en) Production of dicyanamide metal salt
JPS5822140B2 (en) Production method of β-chloroalanine
JP2659667B2 (en) Method for producing cystamine